Stock Events

Stock Events

Dechra Pharmaceuticals 

$98.00
89
+$1.90+1.98%Friday 15:28

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Aug 2026
$0.41
May 2026
$0.41
Feb 2026
$0.41
Nov 2025
$0.41
Aug 2025
$0.41
10Y Growth
20.14%
5Y Growth
0.32%
3Y Growth
-2.34%
1Y Growth
-3.49%

Earnings

Jun 30Expected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
0
0.07
0.14
0.2
Expected EPS
0
Actual EPS
0.2046

Financials

8.73%Profit Margin
Profitable
2017
2018
2019
2020
2021
2022
874.75MRevenue
76.36MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regency Centers
REG
Mkt Cap13.11B
Regency Centers Corporation specializes in shopping centers, directly competing with Cedar Realty's focus on retail properties.
Federal Realty Investment Trust.
FRT
Mkt Cap9.27B
Federal Realty Investment Trust is known for its high-quality retail and mixed-use properties, making it a direct competitor in the retail space.
Kimco Realty
KIM
Mkt Cap14.92B
Kimco Realty Corporation is one of the largest publicly traded owners and operators of open-air shopping centers, a direct competitor to Cedar's retail focus.
Brixmor Property Group
BRX
Mkt Cap8.41B
Brixmor Property Group operates a national portfolio of open-air shopping centers, positioning it as a competitor in the retail real estate market.
SITE Centers
SITC
Mkt Cap179.47M
SITE Centers is a real estate investment trust that focuses on shopping centers, making it a competitor in the retail property sector.
Urban Edge Properties
UE
Mkt Cap2.49B
Urban Edge Properties, a real estate company focusing on retail properties in urban communities, competes with Cedar Realty in the retail market.
Acadia Realty Trust
AKR
Mkt Cap2.56B
Acadia Realty Trust is focused on the acquisition, development, and management of retail properties, competing with Cedar Realty in the retail real estate sector.

About

Pharmaceuticals: Other
Health Technology
Manufacturing
Pharmaceutical Preparation Manufacturing
Cedar Realty Trust, Inc. is a real estate investment trust that focuses on owning and operating income-producing retail properties with a primary focus on grocery-anchored shopping centers, predominantly located in the Northeast. It is a wholly owned subsidiary of Wheeler Real Estate Investment Trust.
Show More
CEO
Michael Andrew Franklin
Employees
55
Country
United States
ISIN
US2434351043
WKN
000A3DRF5

Listings

XNYS
US
CDR-PB
XNYS
US
CDR-PC
STU
DE
1PK.STU
F
DE
1PK.F

0 Comments

Share your thoughts

FAQs

What is Dechra Pharmaceuticals stock price today?▼
The current price of DPHAY is $98.00 USD — it has increased by +1.98% in the past 24 hours. Watch Dechra Pharmaceuticals stock price performance more closely on the chart.
What is Dechra Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Dechra Pharmaceuticals stocks are traded under the ticker DPHAY.
What were Dechra Pharmaceuticals earnings last quarter?▼
DPHAY earnings for the last quarter are 0.2 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Dechra Pharmaceuticals revenue for the last year?▼
Dechra Pharmaceuticals revenue for the last year amounts to 874.75M USD.
What is Dechra Pharmaceuticals net income for the last year?▼
DPHAY net income for the last year is 76.36M USD.
Does Dechra Pharmaceuticals pay dividends?▼
Yes, DPHAY dividends are paid semi-annual. The last dividend per share was 0.78 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Dechra Pharmaceuticals have?▼
As of October 13, 2026, the company has 55 employees.
In which sector is Dechra Pharmaceuticals located?▼
Dechra Pharmaceuticals operates in the Real Estate sector.
When did Dechra Pharmaceuticals complete a stock split?▼
Dechra Pharmaceuticals has not had any recent stock splits.
Where is Dechra Pharmaceuticals headquartered?▼
Dechra Pharmaceuticals is headquartered in Virginia Beach, United States.